This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Procell Therapeutics Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: **Innovations by Inventor Kisuk Park**
Introduction
Kisuk Park, an esteemed inventor based in Seoul, South Korea, has made significant contributions to the field of biotechnology. With a focus on developing innovative therapeutic solutions, his work primarily revolves around recombinant proteins and their applications in cancer treatment.
Latest Patents
Kisuk Park holds two notable patents that showcase his inventive capabilities. The first patent is for "Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same." This invention reveals how a macromolecule transduction domain (MTD) can be fused to the metastasis suppressor Nm23. The research details the effectiveness of these proteins in preventing cancer metastasis by inhibiting the proliferation, differentiation, and migration of cancer cells. The second patent involves "Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same." This work focuses on fusing a macromolecule transduction domain to the tumor suppressor p18, which enhances its capacity to elicit cellular responses to DNA damage and oncogenic signals, thus showcasing potential in cancer therapies.
Career Highlights
Kisuk Park works with Procell Therapeutics Inc., where he leverages his expertise to drive forward the development of groundbreaking medical technologies. His career reflects a dedication to enhancing treatment methodologies, particularly in oncology, enabling better patient outcomes through innovative approaches.
Collaborations
Throughout his career, Kisuk has collaborated with talented colleagues, including Daewoong Jo and Thi Thuy Nga Do. These partnerships have contributed to the advancement of his research and the successful execution of complex projects in the biotechnological space.
Conclusion
Kisuk Park's inventions in the realm of recombinant proteins hold promise for advancing cancer treatment modalities. With his patents illustrating significant therapeutic potential, his work is pivotal in the ongoing battle against cancer metastasis, showcasing the vital role of inventors in medical innovation. As he continues his work at Procell Therapeutics Inc., the scientific community looks forward to his future contributions to biomedicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile